Pivekimab, a human IgG1 monoclonal antibody, targets interleukin 3 (IL-3) and CD123. It is utilized in researching blastocytic plasmacytoid dendritic cell tumor (BPDCN) [1].
CAS Number:
[2234335-84-1]
* VAT and and shipping costs not included. Errors and price changes excepted
